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Intestinal intraepithelial lymphocyte activation
promotes innate antiviral resistance
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Unrelenting environmental challenges to the gut epithelium place particular demands on the
local immune system. In this context, intestinal intraepithelial lymphocytes (IEL) compose a
large, highly conserved Tcell compartment, hypothesized to provide a ﬁrst line of defence via
cytolysis of dysregulated intestinal epithelial cells (IEC) and cytokine-mediated re-growth of
healthy IEC. Here we show that one of the most conspicuous impacts of activated IEL on IEC
is the functional upregulation of antiviral interferon (IFN)-responsive genes, mediated by the
collective actions of IFNs with other cytokines. Indeed, IEL activation in vivo rapidly provoked
type I/III IFN receptor-dependent upregulation of IFN-responsive genes in the villus
epithelium. Consistent with this, activated IEL mediators protected cells against virus
infection in vitro, and pre-activation of IEL in vivo profoundly limited norovirus infection.
Hence, intraepithelial T cell activation offers an overt means to promote the innate antiviral
potential of the intestinal epithelium.
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I
ntraepithelial lymphocytes (IEL) compose a very large T cell
compartment conserved in all vertebrates. Thus, intestinal
IEL exist from ﬁsh through mice to humans. Despite their
conservation, and their decades’-old description, IEL remain very
poorly understood, particularly in humans1. This situation cannot
sustain, given the cells’ juxtaposition to the intestinal microbiota
that are increasingly acknowledged to regulate many aspects of
health and disease. Thus, there is a growing pressure to use
animal models to clarify the diversity and basic biology of IEL.
Murine small intestinal IEL comprise roughly equal numbers of
gd and ab T cells. One type of IEL (previously termed Type a)
expresses T cell antigen receptor (TCR)ab and CD8ab and
comprises mostly Tissue-resident memory (TRM) cells recruited to
the epithelium after systemic priming1,2. The second type of IEL
(Type b) expresses either TCRab or TCRgd, and is either CD8aaþ
or CD8CD4 (so-called double negative cells). Type b IEL are
the more common type in unchallenged mice and seemingly enter
the small intestinal epithelium directly upon maturation, rather
than experiencing a systemic phase3. Furthermore, many are
considered to be agonist selected and reactive to auto-antigens,
although there is scant direct evidence for this4.
Both IEL sub-compartments contain cells that can be rapidly
activated via TCR-dependent and/or TCR-independent stimula-
tion, permitting them to inﬂuence the afferent phase of an
immune response rather than solely the delayed efferent phase—
the traditional arena of T cell responses1,5. Many studies have
focused on the potent cytotoxicity of activated IEL6, their
promotion of epithelial repair7, and their capacity to recruit
other immune-protective and immune-regulatory cells. Indeed,
within hours of activation, skin and/or gut IEL can produce very
large amounts of biologically active soluble mediators, including
granzymes, cytokines and chemotactic factors6–8. Conversely, the
potential of IEL to contribute key, anti-pathogen responses has
not been so clear.
Given the plethora of bacteria in the gut and its potential to
regulate T cell composition and function9–11, there has
predictably been interest in the role of IEL in anti-microbial
responses. Thus, recently reported work, consistent with the
contribution of TCRgdþ IEL to the immediate phase of immune
responses, demonstrated the cells’ capacity to limit bacterial
dissemination during the ﬁrst few hours following infection with
Salmonella enterica ser. Typhimurium. This activity was mainly
dependent on cell-intrinsic production of the antibacterial
defensin, RegIIIg12. Likewise, earlier work demonstrated both
immunoregulatory and immunoprotective roles for murine IEL
in the response to the natural and ubiquitous gut-tropic infectious
protozoan parasite, Eimeria13–15.
Enteroviruses, including coxsackieviruses, rotavirus and nor-
ovirus, cause debilitating disease in neonates, but often much
milder disease in adults, a phenomenon frequently attributed to
the relative immaturity of the neonatal gut immune compart-
ment16. Of note, IEL numbers are low at birth and during
weaning, but expand substantially thereafter, coinciding with the
reduced susceptibility of adult mice to multiple viruses4,17,18.
Added to this, IEL expand after systemic infection with
lymphocytic choriomeningitis virus19 and during oral infection
by reovirus and rotavirus20,21. Within 48 h of infection, interferon-
g (IFNg) production was increased, as was the cells’ cytotoxic
activity. Moreover, the cytotoxic activity of primed IEL speciﬁcally
targeted virus-infected cells in culture22. Collectively, these
ﬁndings strongly argued for the further investigation of how IEL
activation might promote virus-resistance within the epithelium.
To accomplish this, we have employed two strategies. First, a
recently developed protocol for culturing IEL-permitted
IEL–intestinal epithelial cell (IEC) interactions to be studied
in vitro. Second, these interactions were validated in vivo by
examining the molecular and biological impact upon IEC of IEL
activated by the intraperitoneal (i.p.) administration of anti-CD3.
Unexpectedly, one of the most conspicuous impacts of activated
IEL upon IEC was the upregulation of IFN-stimulated genes
(ISGs) and of the antiviral response, attributable to the production
of type I, II and III IFNs by IEL. Consistent with this, activated IEL
supernatants rendered epithelial cells more resistant to virus
infection in vitro. Moreover, T cell activation in vivo rapidly
induced ISGs in the villus epithelium in mice, corresponding with
greatly enhanced resistance to murine norovirus (MNV) within
40 h of gastrointestinal infection. By identifying a novel and
powerful potential for intestinal T lymphocytes to regulate the
innate antiviral defences of the surrounding stroma, these ﬁndings
underline the innate-like biology of the IEL compartment and its
importance for body surface integrity.
Results
IEL activate antiviral responses in epithelial cells. To examine
how soluble effectors produced by activated IEL might impact
upon IEC, we prepared microarray gene expression proﬁles of the
widely used, murine small intestinal epithelial cell line MODE-K
after treating it for 18h with supernatants of IEL that had been
exposed for 24 h either to agonistic TCR cross-linking or to control
antibodies. Because IEL rapidly die ex vivo, particularly when
challenged with TCR agonists, activated IEL supernatants are
invariably contaminated with products of stressed and dying cells.
To avoid this, a recently developed culture system (ref. 23 and see
Methods) was employed that maintains IEL in a highly viable state
for over 2 weeks, permitting them to be grown out and rested
before re-activation. Relative to the starting preparation, the
cultures at 13 days post-establishment comprised essentially pure
T cells (Supplementary Fig. 1a,b), removing, for the ﬁrst time, the
possibility that mediators attributed to IEL might be the products
of contaminating cell types. The cultures largely preserved the
subset composition of the gd T cell compartment (Supplementary
Fig. 1a,b), thereby permitting assay of type b IEL. The subset
complexity of TCRabþ IEL, comprising both type a and type
b cells was also preserved, albeit that the cells’ relative repre-
sentation changed over time (Supplementary Fig. 1a,b).
The IEL were re-activated by exposure to plate-bound anti-CD3
(ref. 23) following which supernatants were collected. RNA
expression proﬁles from MODE-K cells treated with activated
and resting IEL supernatants from several biologically independent
cultures were analysed and compared on an Illumina platform. By
comparison to medium alone or to supernatant from unstimulated
IEL, the supernatant of anti-CD3-activated IEL profoundly
impacted upon MODE-K cells, with many genes overtly
upregulated, and others strongly downregulated (Fig. 1a). This
study focuses on the unexpected ﬁnding that 22 of the 50 most
upregulated genes related to antiviral functions (Table 1). Indeed,
Metacore Genego pathway enrichment analysis showed that the
top four pathways upregulated comprised IFN-regulated genes
associated with antiviral activity (Fig. 1b), including Mx2, Rsad2
(Viperin), multiple Oas genes, Iﬁt3 and Bst2 (Tetherin; Table 1).
The upregulation of ISGs in MODE-K cells cultured either
with IEL supernatant or with IEL in the presence of anti-CD3
was conﬁrmed by quantitative reverse transcription–PCR
(qRT–PCR), extending the ISGs analysed to other
well-characterized examples, for example, Iﬁt1, Mx1, Adar,
Oas1g and Pkr (eif2ak2) (Fig. 1c). Although some other ISGs,
for example, Iﬁh1 (MDA5) and Iﬁtm1/2 were not upregulated, it
is known that different cell types stimulated with IFNs under
different circumstances induce discrete sub-groups within the full
spectrum of ISGs24–26.
IEL supernatants were initially applied to MODE-K cells for
18 h. However, subsequent experiments showed that some ISGs
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were upregulated within 6 h, strongly suggesting them to be direct
responses to activated IEL effectors (Supplementary Fig. 1c).
Moreover, increases in expression could be achieved with
supernatants from IEL that had been activated for just 2–3 h,
implying that the IEL mediators responsible for the induced
antiviral signatures in epithelial cells were produced immediately
upon anti-CD3 stimulation (Supplementary Fig. 1d). Last and
notably, both TCRabþ and TCRgdþ IEL could evoke this
response in MODE-K cells, as stimulation of essentially pure,
IEL-derived T cell cultures (Supplementary Fig. 1b) with either
anti-TCRb or anti-TCRgd antibodies induced the IEC response
signature (Supplementary Fig. 1e).
Activated IEL upregulate type I and III IFNs. ISGs are induced
by IFNs, primarily type I IFN (including IFN-a/b) and
type III IFN (IFN-l2, l3, also known as interleukin (IL)-28a,b
in the mouse)24–26. To test whether activated TCRgdþ
and/or TCRabþ IEL produce IFNs, IEL were this time
ﬂow-sorted ex vivo to substantially pre-enrich for either
TCRabþ or TCRgdþ CD8aa IEL (Supplementary Fig. 2a),
and then cultured for 12–14 days before being stimulated for
2 h by anti-CD3 stimulation. Although the composition of
the sorted cells changed somewhat in culture, the respective
subsets remained greatly enriched for TCRabþ IEL and gd
IEL (Supplementary Fig. 2b), and in each case, substantial
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Figure 1 | IEL supernatant (SN) induces antiviral defence pathways in IEC. (a) Hierarchical clustering of differentially expressed genes in MODE-K cells
treated with SN from unstimulated cultured IEL and SN from IEL activated on plate-bound anti-CD3 for 24 h, in comparison to genes expressed in
MODE-K cultured in medium alone. Heatmap key: red¼ higher expression, blue¼ lower expression relative to the mean expression of the gene across all
samples. (b) Genes upregulated in MODE-K by stimulated IEL SN relative to unstimulated IEL SN were subjected to enrichment analysis using Metacore.
Shown are the top ten statistically signiﬁcant pathways, calculated using an adjusted P value of 0.05. (c) Conﬁrmation by qRT–PCR of upregulation of some
antiviral genes. MODE-K cells were cultured for 18 h with medium, anti-CD3, or SN from cultured IEL as in a. Data are the mean and s.e.m. of three to ﬁve
independent experiments calculated as fold change relative to the untreated samples. See also Supplementary Fig. 1.
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increases in Ifna mRNA were provoked by TCR agonist
stimulation (Fig. 2a). Ifnl mRNA was also rapidly upregulated
albeit to a lesser extent than known products of IEL activation
such as tumour necrosis factor (TNF) and IFNg (Fig. 2a).
These results were consistent with the ﬁnding (above)
that either anti-TCRb or anti-TCRgd antibody treatment of
IEL cultures induced the IEC response signature. We therefore
checked that similar responses would be induced in IEL
that were ﬂow-sorted directly ex vivo, brieﬂy rested, and
then activated before any culturing. Indeed, they too upregulated
transcription of Ifna, Ifnl and Ifng mRNAs (Supplementary
Fig. 2c).
Of note, supernatants of cultured IEL that had been activated for
18 h accumulated IFNa sufﬁcient to be easily measurable by ELISA
(Fig. 2b), and to trigger luciferase expression in cells transfected
with an ISRE-containing promoter responsive to type I and type III
IFNs (Fig. 2c). Thus, TCR-mediated activation of IEL can rapidly
trigger functionally competent type I and type III IFNs, in addition
to its induction of conventional T effector cytokines.
TCR-triggered production of type I IFNs has been previously
documented in CD8þ T cells27, but the pathway leading to this
induction was not elucidated. The transcription of type I and
type III IFNs is generally induced by Interferon Regulatory
Factors, IRF3 and IRF7 (refs 28,29), contingent on their
phosphorylation by TBK1/IKKe that promotes their nuclear
translocation and transcriptional targeting30. Consistent with
their expression of type I and type III IFNs, IEL constitutively
express Irf7 mRNA, which encodes a limiting transcriptional
regulator of IFN production (Supplementary Fig. 2c; Serial
analysis of gene expression data, gene expression omnibus (GEO)
accession code GSE63090 (ref. 6)), while TCR triggering of
resting IEL induced phosphorylation of TBK1/IKKe on the
activation loop Ser172 (Fig. 2d and Supplementary Fig. 2d).
Furthermore, the induction after 2 h of Ifna and Ifnl mRNAs was
clearly reduced by inhibition of IKKe/TBK1 by MRT67307 (ref.
31), whereas this had little effect on Ifng upregulation, which was
instead reduced by NG-25 that inhibits TAK1 (albeit with some
impact on Lck; Fig. 2e). The fact that NG-25 also inhibited Ifna
and Ifnl mRNA induction is consistent with TCR-dependent
TAK1-mediated phosphorylation of TBK1/IKK. Collectively,
these data offer a basic molecular mechanism by which type I
and III IFNs may be induced in IEL directly by TCR triggering.
The co-expression by activated IEL of type I, II and III IFNs
and TNF is provocative given that these may cooperatively and
variably regulate different gene sets. For example, blocking the
type I IFN receptor (IFNAR-1) on MODE-K cells during culture
with IEL supernatant substantially impaired induction of Mx1,
Usp18 and other ISGs (Supplementary Fig. 3a), whereas the
blocking antibody did not affect Irf1, which is known to be
induced very strongly by IFNg and not by IFNa (ref. 24;
Supplementary Fig. 3a). Indeed, upregulation of each gene tested
was reduced to baseline levels by simultaneously blocking the
response to more than one IFN/cytokine. We did not use
blocking antibodies against IFNlambda receptor (IFNLR, IL28R),
as MODE-K cells do not express mRNA for this receptor
(Supplementary Fig. 3b). However, because IFNl produced by
IEL may also contribute in vivo to ISG upregulation in primary
epithelial cells expressing IFNLR, the studies described below
continued to focus on both type I IFN and IFNl (type III IFN).
Activated IEL protect epithelial cells from virus infection.
If activated IEL supernatant is a source of type I IFN and IFNl,
we would predict that it should protect cells from virus infection.
To test this, supernatant of cultured IEL, with or without TCR-
mediated stimulation (Act or Unstim) was added to MODE-K
cell cultures that were then infected with encephalomyocarditis
virus (EMCV), which induces a cytopathic effect in many murine
cell types. As indicated by crystal violet staining of living cells
(Fig. 3a,b), EMCV efﬁciently killed MODE-K cells even at low
multiplicity of infection (MOI). This cytopathic effect was
reduced by adding anti-CD3-activated IEL supernatant to
MODE-K cells before infection, whereas supernatants from
resting IEL had no appreciable effect (Fig. 3c). The protective
effect was roughly comparable to that of 500Uml l of recom-
binant IFNa, showing the potency of IEL activation in protecting
Table 1 | Top 50 genes upregulated by activated IEL
supernatant activity in MODE-K cells, relative to treatment
with unstimulated IEL supernatant*.
Gene symbol Fold upregulation P value
1 Gbp1 65.55766376 3.95E-021
2 Cxcl10 58.95340945 1.53E-014
3 Gbp2 45.85247206 6.76E-020
4 Igtp 40.83377732 1.15E-020
5 Iﬁt3 31.77914902 3.42E-020
6 Parp14 31.21626222 1.53E-019
7 Cxcl9 29.62707481 1.29E-013
8 Gbp3 28.79272785 2.12E-021
9 Irgm2 23.32336086 1.76E-019
10 Usp18 20.3973229 1.71E-015
11 Serpina3f 19.21505748 5.53E-019
12 Cd274 18.76071204 3.20E-017
13 Oas1g 16.84099589 2.24E-017
14 Uba7 16.65088632 1.20E-017
15 Isg15 15.20627377 2.76E-020
16 Ubd 14.98105332 1.05E-015
17 Tap2 14.66831575 4.86E-014
18 Iﬁ47 13.4774931 2.36E-017
19 Oasl2 12.64280486 6.04E-015
20 Cxcl1 12.61727906 1.55E-015
21 Serpina3g 12.40164805 3.76E-015
22 Bst2/Tetherin 12.22500541 4.71E-012
23 Irgm1 12.0682483 8.27E-020
24 Batf2 12.00016517 3.09E-016
25 Casp4 11.92209136 5.60E-015
26 Mx2 11.8635847 5.14E-014
27 Gbp6 11.36566559 1.15E-015
28 Ly6a 11.00935367 2.41E-017
29 Psmb10 10.89082162 4.22E-014
30 Irf1 10.86880156 7.63E-016
31 Rsad2/Viperin 10.59057187 1.56E-014
32 Clec2d 9.59559145 3.03E-018
33 Gvin1 9.352420697 3.19E-016
34 H2-T23 9.232998263 2.56E-020
35 Ccl5 8.209346619 1.70E-007
36 Oas2 8.03980934 8.21E-015
37 Il15 7.420256815 1.19E-015
38 Samd9l 7.264056178 5.63E-016
39 Tap1 7.198593767 4.95E-017
40 Lgals3bp 7.069264112 2.35E-013
41 Stat1 6.934514582 3.55E-014
42 Hap1 6.666286165 1.55E-014
43 Ly6c1 6.544184369 1.98E-016
44 Tgtp 6.533063036 2.05E-017
45 Ube2l6 6.319678326 6.88E-017
46 Tapbp 5.946552674 9.86E-011
47 Il1rl1 5.882100485 3.19E-011
48 Fas 5.870197407 1.72E-015
49 Ccl2 5.760057637 3.58E-007
50 Trim21 5.550994810 4.38E-017
IEL, intraepithelial lymphocyte.
*Only one probe per gene and only known genes are shown, and those involved in antiviral
pathways or with putative antiviral function are highlighted.
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epithelial cells from virus. It was partially blocked by antibodies to
the type I IFN receptor (IFNAR-1), or by blocking the three
effectors, type I IFN, IFNg and TNF together (Fig. 3b,c). Thus, in
the absence of any additional cell types, soluble mediators pro-
duced by activated IEL increased the antiviral resistance of IEC.
IEL activation in vivo induces a rapid antiviral response.
Although the data to this point were derived by use of the
MODE-K cell line, they clearly provoked the hypothesis that IEL
activation induces antiviral response genes in neighbouring epi-
thelial cells in vivo. To test this, a single low dose of anti-CD3 was
administered i.p. Relative to mice receiving isotype control anti-
bodies, antiviral genes were clearly rapidly upregulated (within
3 h; Fig. 4a), with a gradient of induction broadly correlating with
IEL density along the length of the small intestine32. By
fractionating total epithelium from the small intestine, the
induction of Ifna, Ifnl, Ifng and Tnf could be attributable to the
CD45þ fraction (mainly CD8aþ TCRabþ and TCRgdþ IEL,
see Supplementary Fig. 4a), whereas the antiviral genes were
upregulated in the CD45 fraction (B80% EpCAMþ IEC,
Supplementary Fig. 4a and Fig. 4b,c). Peak induction for some
genes was at 3 h, with some mRNAs returning to baseline by 6 h
(Supplementary Fig. 4b,c), emphasizing how rapid are the effects
of activated T cells on epithelial cells in vivo.
At the 3 h time point at which gene expression was assayed,
there was no major damage to the epithelial layer and no major
immune cell inﬁltration (Supplementary Fig. 4d,e). However,
because there was some villus blunting reminiscent of intestinal
inﬂammation33, it was appropriate to consider other possible
lymphocyte sources of T cell activation-dependent Ifn gene
expression. Thus, i.p. injection of anti-CD3 was repeated in WT
mice and 3 h later the epithelial and lamina propria (LP)
compartments separately isolated from the same guts (ﬂow
cytometry data of isolated IEL are shown in Supplementary
Fig. 4f,g). qRT–PCR on the extracted layers clearly showed that
IFNa and IFNl gene upregulation almost exclusively segregated
with IEL, which also showed signatory high IFNg RNA induction
(Fig. 4d). Conversely, the LP fraction displayed preferential
induction of Il17a, a known signature of LP lymphocytes, but
negligible Ifna upregulation, and very weak Ifnl upregulation.
Thus, there was no basis for conjecturing that intestinal T cell-
dependent induction of anti-viral effectors in vivo reﬂected the
activity of LP T cells.
Also at 3 h after TCR triggering in vivo, we isolated splenic
T cells, inguinal lymph nodes (LNs) and IEL that were ﬂow-sorted
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Figure 2 | IEL produce type I and III IFN upon stimulation through activation of TBK1. (a) qRT–PCR showing expression of type I, II, III IFN mRNA and
TNF mRNA in IEL sorted into TCRgdþ CD8aaþ and TCRabþ CD8aaþ subsets, cultured and then stimulated with anti-CD3 for 2 h (red bars). Data are
the mean and s.e.m. of IEL from three mice. (b) IFNa was measured in resting and activated (18 h) IEL (cultured) supernatant by ELISA. Each point
represents an independent culture, n¼ 7. (c) IEL supernatant was assayed for the presence of active IFN by ISRE-luciferase reporter assay, n¼4.
Statistical signiﬁcance was calculated in a–c by two-tailed unpaired t-tests, *Po0.05, **Po0.01, ***Po0.001. (d) Cultured gdTCRþ IEL were stimulated on
plate-bound anti-CD3. The cells were then lysed and analysed by western blotting for phosphorylation of TBK1 (S172), total TBK1 and the loading control
TBP (full blots are shown in Supplementary Fig. 2d). Data are representative of four independent cultures. (e) IEL were pre-treated with 1 mM of each of the
following inhibitors for 1 h (NG-25 (TAK1 inhibitor) and MRT67307 (TBK1/IKKe inhibitor)), before stimulation on anti-CD3 for 2 h. mRNA for IFNa, IFNl
and IFNg were measured by qRT–PCR (Uns¼ unstimulated). Mean and s.e.m. of four technical replicates are shown, and the data represent two
independent experiments. DMSO, dimethylsulphoxide.
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into the main unconventional T cell populations (TCRabþ
CD8aaþ IEL and TCRgdþ CD8aaþ IEL; Supplementary
Fig. 4h). Splenic CD8 T cells and LN cells upregulated Ifna RNA
to some extent, consistent with previous reports27, and Ifng mRNA
very strongly, but they did not upregulate Ifnl RNA. Conversely,
only puriﬁed IEL factions showed reproducible upregulation of
RNAs encoding all IFN subtypes (Fig. 4e). (The relative attenuation
of the type I IFN response probably reﬂects the fact that this is only
a transiently induced gene-set relative to the time (B7 h) required
for harvesting tissue and ﬂow cytometry-based cell sorting before
RNA preparation.) Interestingly, the mild villus blunting apparent
by histology (Supplementary Fig. 4d,e) has previously been
associated with IFNa treatment of mice34, possibly reﬂecting
anti-CD3 induced type I and type III IFN expression by IEL.
ISG upregulation in vivo depends on IFNa and IFNk receptors.
To test the contribution of type I and type III IFNs to ISG
upregulation in vivo, anti-CD3 was administered i.p. to mice
mutant for one or both IFN receptor subtypes. The levels of
induction of many ISGs were reduced in Ifnar1 / mice,
commonly to a greater degree in Ifnlr1 / mice, and most often
to an even greater degree in Ifnar1 / Ifnlr1 / double
knockout (DKO) mice (Fig. 5a). Of note, the rapid induction of
Irf1, which depends primarily on IFNg (see Supplementary
Fig. 3a), was little impaired in Ifnar1 / Ifnlr1 / DKO mice.
To check if antiviral protein was induced by T cell activation
in vivo, a C57BL/6 strain was employed that harbours functional
alleles of Mx1, which is a pseudogene in wild–type C57BL/6
mice35. Mx1 protein rapidly accumulates in the nucleus following
induction via type I or type III IFN receptors but not via
IFNgR36,37. Under steady-state conditions, a well-characterized
antibody against Mx1 (refs 37,38) detected the speciﬁc punctate
nuclear stain for Mx1 protein in a very small number of LP cells
(Fig. 5b and Supplementary Fig. 5a; note that the homogeneous
cytoplasmic stain seen in some LP cells reﬂects a background
signal seen also in some Mx1-deﬁcient mice, Supplementary
Fig. 5b). Conspicuously, the punctate nuclear pattern of Mx1
protein was overtly upregulated in isolated or clustered cells
throughout the epithelium, consistent with an ongoing IFN
response (Fig. 5b and Supplementary Fig. 5a). This activation-
induced expression pattern was not seen in intestines of Ifnar1 /
 Ifnlr1 / DKO mice after anti-CD3 stimulation (Fig. 5b and
Supplementary Fig. 5a), establishing that its TCR-driven
upregulation depended on type I/type III IFN.
Pre-activation of IEL reduces susceptibility to norovirus
infection. MNV is an enteric non-enveloped positive-sense,
single-stranded RNA virus (family calicivirus) naturally prevalent
among mice39,40. Multiple strains of this virus have been isolated
that cause either acute or persistent asymptomatic infection in
immunocompetent mice39,41. Mice are infected by the faecal-oral
route with evidence for infection of gastrointestinal epithelial
cells, macrophages and dendritic cells39,42. The capability to grow
MNV in macrophage cell lines and then to infect its natural host
make it an important animal model for infection by caliciviruses,
including human norovirus. Furthermore, the growth of MNV is
greatly inhibited by IFNs, particularly IFNl (ref. 43).
Therefore, to test whether prior TCR-dependent activation in
the gut might increase epithelial resistance to norovirus, mice
were infected orally with MNV-O7 (ref. 44) 8 h after pre-
inoculation with either control or agonistic anti-CD3 antibodies
i.p. After 40 h (a time point chosen to ensure detection of virus-
infected cells), the intestines and mesenteric LNs from infected
and uninfected controls were isolated, and levels of virus
replication assessed by live virus titration (TCID50 assay; Fig. 6a
and Supplementary Fig. 6a), and by qRT–PCR for viral RNA
(ORF2; Fig. 6b and Supplementary Fig. 6b), expressed in each
case on a logarithmic scale. Notwithstanding some variation
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between groups, live virus was readily detected by TCID50 assay
in cells harvested from infected mice or from infected mice pre-
treated with an isotype-control antibody, with consistent results
obtained by qRT–PCR. However, when measured by either assay,
the level of infection was reproducibly and substantively
decreased in independent experiments in which mice were
pre-treated with anti-CD3 (Fig. 6). Even in one case where the
reduction in anti-CD3 pre-treated mice was not statistically
signiﬁcant (in proximal small intestine, as measured by the
TCID50 assay (Fig. 6a)), it was noteworthy that no virus could be
detected in those mice (0/6), by comparison to the detection of
virus in the small intestines of 5 out of 12 mice of the control
groups, and that signiﬁcance was reached when the same tissue
was assayed by reverse transcription–PCR (Fig. 6b). Consistent
results were obtained whether virus copy number was assessed
relative to a control gene (Fig. 6b) or to mass of tissue
(Supplementary Fig. 6b). Note too, that the results are not
consistent with large amounts of virus in anti-CD3-treated mice
translocating from the intestine into systemic compartments,
as the viral load was also dramatically reduced (between
10-fold and 100-fold) in the mesenteric LNs, consistent with
there being a severe overall attenuation of infectious virus
(Fig. 6a). Thus, TCR-dependent IEL activation in vivo function-
ally enhances innate resistance to norovirus.
Discussion
The very clear ﬁnding of this study is that upon activation,
intestinal intraepithelial T cells can functionally promote innate
antiviral immunity in neighbouring cells thereby contributing to
timely host protection. Two questions immediately arise. The ﬁrst
question is the type of scenario in which IEL will be activated via
the TCR. The IEL compartment is one of the largest in the body
and broadly conserved across vertebrates. Data presented in this
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study show that multiple types of intestinal IEL can invoke
antiviral effects. This is consistent with two recent studies of TRM
cells, although neither study explored the functional potential of
TRM cells beyond their production of conventional T cell
mediators, particularly IFNg and TNF45,46. Type a IEL will
likely include virus speciﬁc, memory CD8þ TRM cells, deposited
in the epithelium following prior infection47–50, and rapidly
re-activated via the presentation of viral peptides by infected
epithelial cells. Moreover, there may be biological utility to
bacteria-/parasite-speciﬁc IEL activating anti-viral immunity,
given recent work showing how gastrointestinal bacteria may
facilitate virus infection51,52.
The physiologic TCR stimuli for Type b IEL have not been
determined, but they are widely considered to include self-
antigens that reﬂect cellular stress or dysregulation that is a
consequence of infection. Such TCR-mediated responses can be
aided by detection of ‘stress-ligands’ for the activating NKG2D
receptor that is particularly strongly expressed by human
intestinal IEL. Indeed, NKG2D is such an important component
of anti-viral T- and NK cell responses that widely diverged viruses
have each developed distinct immuno-evasive mechanisms53. In
addition, IEL can respond to IL-15 that can be produced in high
amounts by infected IEC54,55. Hence, via responses to antigen,
NKG2D ligands, and ‘cytokine alarmins’, Type b IEL may
contribute to the innate phase of antiviral immunity via their
sensing of the status of the tissue5. In so doing, the antiviral
effects of IEL activation would complement other impacts
of IEL on IEC survival, differentiation and turnover56,57: the
aggregate effect being to eradicate potentially dangerous infected
epithelial cells; to promote repair of an intact epithelium; and to
reduce susceptibility to further virus infection. By these several
means, T cells can play a key role in the early phase of the
response to challenge, an arena ordinarily assigned to innate
myeloid cells.
The second question would ask whether activated IEL (and
possibly other T cells) are over-looked, inducible sources of IFNs.
Of note, the anatomical restriction of IFNl production to the
epithelial layer of the intestine ﬁts with the restriction of the IFNl
receptor expression to epithelial cells and barrier surfaces.
Moreover, IEL express Irf7 that encodes the major transcriptional
regulator of type I and type III IFNs. IRF7 is itself a target of the
type I IFN response, indicating that IEL themselves are probably
responding to low levels of IFNs that they constitutively produce.
Of note, a study by Ogasawara et al. of splenic CD8þ T cells also
noted the cells’ autocrine response to their own low levels of type I
IFN27. We have now indicated roles for the key kinases upstream
of IRF7 activity, TBK1 and/or IKKe, upon TCR-triggering of IEL.
Furthermore, the Ifnb1 and Ifnl3 promoters also contain nuclear
factor-kB-responsive elements, potentially providing an additional
link of TCR triggering to the induction of IFNs29,58.
The impact of activated IEL supernatants on upregulating
antiviral effectors in epithelial cells is rapid, most likely direct, and
inhibited in vitro and in vivo by blocking or removing type I and
type III IFN receptors. As noted previously, not all known ISGs
were upregulated in epithelial cells. This may partially depend on
the cohort of signal transducers and activators of transcription
factors that are activated downstream of the respective IFN
receptors, as has been shown for the differential response of
lymphocyte subsets to IFNb59. However, this study also
emphasizes that the antiviral effect is promoted by a
collaboration of type I and/or type III IFN with type II IFN
and TNF that collectively comprise signature products of IEL.
This collaboration can occur at multiple levels, involving receptor
cross-talk at the level of the membrane, and further downstream,
through the signalling complexes involved60.
Clearly, our work should not be taken to suggest that IEL are the
exclusive source of IFNs for IEC. Rather, IEL may be important
sources of IFNs in response to antigens and/or to upregulated
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Figure 6 | Activation of IEL is protective against murine norovirus (MNV) in vivo. C57BL/6 mice were orally infected with MNV-O7, without pre-
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NKG2D ligands, neither of which is sensed by myeloid cells.
Interestingly, earlier studies showed that IEC express the type I
IFN receptor apically and not basolaterally, and suggested that this
would make IEC unresponsive to type I IFNs produced by other
cells61. Consistent with this, Mx1 induction in IEC after rotavirus
infection in vivo was more largely dependent on type III IFNs than
on type I IFNs61. Nonetheless, given that IEL extend processes
upwards between IEC, as do dendritic cells, it may be that apical
IFNAR is speciﬁcally responsive to IFNs produced locally by IEL.
It is also the case that the impact of IFNs and the genes that
they induce is not limited to antiviral functions. For example,
protein kinase, dsRNA-activated (PKR), which phosphorylates
the translation initiation factor eIF2a, modulates several stress-
related signalling pathways including autophagy by halting
translation62. Likewise, IFN-responsive transporter associated
with antigen processing-1 (TAP1) is required for major
histocompatibility complex-I antigen presentation in addition to
its more recently discovered antiviral attributes26, and several
IFN-inducible GTPases have antimicrobial activity63. Moreover,
guanylate-binding protein-1 upregulation in IEC strengthens
barrier integrity by reducing epithelial apoptosis64. Thus, IEL
activation may promote such biological activities relevant to body
surface integrity and epithelial turnover.
In sum, this study demonstrates an overlooked role for tissue-
associated T cells in promoting the antiviral innate defences of the
surrounding tissue. This in turn shows that a fundamental
component of innate immunity can be regulated by cells classically
regarded as adaptive cells, re-emphasizing caution in studies of
innate immunity undertaken in scenarios of adaptive immune
dysfunction, such as recombinase activating gene (RAG)-deﬁcient
mice or paediatric lymphocyte deﬁciencies. Finally, there is
increasing public health concern about gastrointestinal virus
infection in the developing and the developed worlds65,66. In
considering the basis for resistance to such infections, it would seem
important to consider potential contributions of T cells, as
considered here. Indeed, T cell production of type I and III IFNs
might usefully be considered in a similar clinical context to T cell
production of cytokines such as IL-17 and IFNg; that is to say, a
potential route to immune enhancement for vaccination strategies
and a target for suppression in the case of autoimmunity,
inﬂammation or graft rejection.
Methods
Mice. Six- to twelve-week-old female C57BL/6 mice were obtained from Charles
River Laboratories (Harlow). B6.A2G-Mx1 wild type mice carrying intact Mx1
alleles (WT), B6.A2G-Mx1-Ifnar1 / mice lacking functional type I IFN recep-
tors (IFNAR knockout (KO)), B6.A2G-Mx1-Ifnlr1 / mice lacking functional
type III IFN receptors (IFNLR KO) and B6.A2G-Mx1-Ifnar1 / Ifnlr1 / mice
(DKO) lacking functional receptors for type I and III IFN were bred at the animal
facility at the University of Freiburg. Animals were housed in accordance with the
guidelines deﬁned by the Federation for Laboratory Animal Science Associations
(http://www.felasa.eu/recommendations) and experiments were performed in
compliance with the German animal protection law (TierSchG) and the Animal
(Scientiﬁc Procedures) Act UK (1986) and approved by the local animal welfare
committees of the Universities of King’s College London, Cambridge, Freiburg and
Dundee.
Cell lines. The MODE-K small intestinal enterocyte cell line was a kind gift of
D. Kaiserlain (U. Lyon, France)67. LL171 cells (L929 cells containing a stable
IFN-stimulated response element-luciferase reporter plasmid (ISRE-Luc)) were a
kind gift from Mireia Pelegrin (Montpellier, France).
Isolation and culture of murine small intestinal IEL. IEL were isolated from
mouse small intestine as previously described23. Brieﬂy, the small intestines
were opened, freed of Peyer’s patches and washed in PBS. The epithelial layer
was gently scraped off using a scalpel, and incubated for 40min in RPMI 1640
containing 10% FCS and 1mM dithiothreitol in a turning wheel. After
centrifugation and vortexing in RPMI, the cells were passed through a nylon wool
column. Isolated cells were centrifuged in a 20%/40%/80% Percoll density gradient
at 700g for 30min. The IEL were harvested from the 40 to 80% Percoll interface.
After isolation, IEL were stimulated on plate-bound anti-CD3 antibody (1 mgml l,
145-2C11, BD, BioLegend) in a cocktail of cytokines (IL-2 (10Uml 1), IL-15
(100 ngml 1) (Immunotools), IL-3 (100Uml 1), IL-4 (200Uml 1) (Roche)).
After 2 days, cells were transferred to fresh plates and cultured with IL-2
(10Uml 1) in RPMI 1640 Supplemented with 10% FCS, 100Uml 1 penicillin,
100 mgml 1 streptomycin, 2mM glutamine, 1mM sodium pyruvate, 1mM b-
mercaptoethanol, 2.5mM HEPES, and non-essential amino acids (all from
Invitrogen). Cells were maintained in 96-well round-bottom plates at a
concentration of 500,000 cells per ml (200 ml per well) at 37 C and 10% CO2.
Medium was replaced completely every 3–4 days.
IEL activation and blocking antibodies. For activation and experiments, IEL were
seeded into 96-well round-bottom plates (70,000–100,000 cells per well in 200 ml)
pre-coated with antibodies against CD3 (145-2C11, BioLegend). In blocking
experiments, IEL supernatants were pre-incubated with antibodies against TNF
(TN3–19), IFNg (R4-6A2; eBioscience), anti-IFNAR (BioLegend). Recombinant
cytokines were purchased from Peprotech.
In vivo IEL activation. C57BL/6 female mice aged 8–12 weeks were intraper-
itoneally injected with 25 or 50 mg anti-CD3e antibody (145–2C11) or an isotype
control (ITC) antibody (both BioLegend, low endotoxin, azide-free) and killed after
3 h. The intestine was excised and ﬂushed with PBS. Samples from different gut
regions were taken for immunohistochemistry and RNA analysis. The remaining
small intestine was cut longitudinally, Peyer’s patches excised and cut into 1 cm
pieces and incubated for 30min in RPMI 1640 containing 10% FCS and 1mM
dithiothreitol at room temperature in a turning wheel. Cells were spun down,
resuspended in RPMI 10% FCS and vortexed for 4min. The released cells were
passed through a 70-mm cell strainer, the remaining tissue was collected and again
vortexed in RPMI 10% FCS for 4min. The released cells were pooled and cen-
trifuged at 700 g for 30min (no brake) in a density gradient of 80/40/20% Percoll.
Puriﬁed IEL and IEC fractions were either directly taken for ﬂow cytometric
analysis, sorting, or further puriﬁed by CD45 magnetic bead columns (Miltenyi).
Puriﬁed cells were used for RNA analysis. The tissue remaining after IEL extraction
was then subjected to a further extraction of the LP layer by digesting the tissue
with Collagenase D (500 mgml 1) and DNase (50mgml 1) for a further 1 h at
37 C. The tissue was mashed through a 70-mm ﬁlter, and the resulting cells also
puriﬁed on a 40% Percoll layer.
Microarray analysis. MODE-K cells were seeded into six-well plates and cultured
overnight. Medium was replaced with supernatant from unstimulated IEL,
supernatant from anti-CD3-stimulated IEL (100% of assay volume), or medium
containing recombinant TNF and IL-1a (10 ngml 1 and 100 pgml 1, respec-
tively). RNA was isolated using the Qiagen RNeasy extraction kit, labelled by the
standard Illumina biotin labelling protocol and analysed on Illumina gene
expression arrays (Mouse Ref. 8 v3) at the Bart’s and the London Genome Centre.
Gene expression data were analysed using Bioconductor 2.2 (http://bioconductor.
org) running on R2.7.1. Normalized probe-set expression measures were calculated
using log2 transformation and quantile normalization using the ‘Lumi’ package. To
determine signiﬁcant differences of expression levels between the different groups,
a moderated Student’s t-test was computed on a gene-by-gene basis using the
empirical Bayes statistics in the ‘Limma’ package. The resultant P-values were
adjusted for multiple testing using the false discovery rate (FDR) Benjamini and
Hochberg method, where any probe sets that exhibited an adjusted P-value FDR
qo0.05 were called differentially expressed. Cluster was used to draw the heatmap
using average linkage clustering to cluster the genes. Differentially expressed probes
were also analysed using Metacore Pathway analysis tool (Thomson Reuters) to
identify enrichment of pathways and processes. The analysis employs a hyper-
geometric distribution to determine the most enriched gene set. Pathways or
processes that showed FDR qo0.05 were called as enriched.
Viruses, stimuli, and cytokine induction assays. EMCV strain pEC9 was a gift
from Dr Ian Kerr. MODE-K cells were plated at 30,000 cells per well in 96-well ﬂat-
bottom plates. The cells were infected with decreasing concentrations of EMCV
starting with an MOI of 100 (3 105 virus particles (leftmost)) then a serial
fourfold dilution was made along the row. One column of cells was left uninfected
to control for cell proliferation and viability. Where indicated, the cells were pre-
treated overnight with 1:1 diluted IEL supernatant, with/without blocking anti-
bodies. Four rows were prepared for each treatment. Twenty-four hours post
infection, cells remaining in the well were ﬁxed and stained with crystal violet. A
clear well indicates cell death by virus infection. To quantify the crystal violet data,
the 8-bit images of 96-well plates were analysed by measuring mean density with
background density subtracted in each well. For stimulation and cytokine induc-
tion assays, MODE-K cells were seeded in 48-well plates at 4 105 cells per ml and
treated with IEL supernatant or recombinant cytokines for 6 h unless otherwise
indicated.
IFNa detection. IFNa was measured by sandwich ELISA as described pre-
viously68. Total IFNa/b were measured by titration on LL171 (ISRE-Luciferase
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containing) cells and compared with recombinant human IFN-A/D used as a
cytokine standard.
Quantitative real-time reverse transcription–PCR. Samples were stored in
RNAlater (Ambion) or directly frozen in RLT buffer, RNA was isolated with a
Qiagen RNeasy kit, transcribed into cDNA and analysed in comparison to TATA
box binding protein (TBP) on a ViiA7 Real-time PCR machine (Applied Biosys-
tems). All primer sequences are provided in Supplementary Table 1.
Immunohistochemistry. Gut tissue was ﬁxed overnight in 10% neutral-buffered
formalin, parafﬁn embedded and sectioned at 4-mm thickness for staining with
mouse anti-Mx1 (clone M143)38 or anti-CD3e (rabbit polyclonal, Dako).
Secondary antibodies used were AlexaFluor 488- and 647-labelled antibodies from
Molecular Probes (Invitrogen). Sections were mounted in Vectashield containing
4,6-diamidino-2-phenylindole to stain nuclei.
Imaging. Images were acquired at room temperature on a Zeiss-LSM710 confocal
microscope with a Plan-Apochromat  40/1.3 Oil/DIC objective and Zen image
acquisition software or on a Leica SP5 laser-scanning confocal microscope
equipped with a  40/1.4 numerical aperture PL APO oil objective. All images
were acquired as z-stacks of 10 mm thickness and maximum projections presented
using the Leica application suite software. Images were exported and processed
using Volocity software (Improvision) or ImageJ.
In vivo virus infection. The MNV strain O7 (MNV-O7) was isolated from the
faeces of a STAT1 / mouse, grown in BV2 cells69 and used at passage 3. The
strain establishes a persistent, and usually non-pathogenic, infection in
immunocompetent mice44. Six- to eight-week-old female C57BL/6 mice were
injected i.p. with either 25mg anti-CD3e antibody (145-2C11) or isotype control
antibody or were left untreated. After 8 h, mice were then infected with 5 106
TCID50 MNV-O7 by oral gavage and killed at 40 h post-infection. Tissues were
removed immediately and the intestine ﬂushed through with PBS before
sectioning. Sections were preserved in RNAlater for qRT–PCR or were frozen at
 80 C for assays to titre live virus. Sections were weighed, homogenized in PBS,
freeze-thawed, supernatant clariﬁed and the resulting supernatant used in limiting
dilution infection assays. Live virus titre was calculated by the Reed-Muench
method70.
Statistics. Statistical analyses were performed using Prism 6.0 (GraphPad), and
the tests used are indicated in the ﬁgure legends. Differences were considered
signiﬁcant when Po0.05.
References
1. Hayday, A., Theodoridis, E., Ramsburg, E. & Shires, J. Intraepithelial
lymphocytes: exploring the Third Way in immunology. Nat. Immunol. 2,
997–1003 (2001).
2. Gebhardt, T., Mueller, S. N., Heath, W. R. & Carbone, F. R. Peripheral tissue
surveillance and residency by memory T cells. Trends Immunol. 34, 27–32
(2013).
3. Hayday, A. & Gibbons, D. Brokering the peace: the origin of intestinal T cells.
Mucosal Immunol. 1, 172–174 (2008).
4. Cheroutre, H., Lambolez, F. & Mucida, D. The light and dark sides of intestinal
intraepithelial lymphocytes. Nat. Rev. Immunol. 11, 445–456 (2011).
5. Hayday, A. C. gd T cells and the lymphoid stress-surveillance response.
Immunity 31, 184–196 (2009).
6. Shires, J., Theodoridis, E. & Hayday, A. C. Biological insights into TCRgdþ
and TCRabþ intraepithelial lymphocytes provided by serial analysis of gene
expression (SAGE). Immunity 15, 419–434 (2001).
7. Chen, Y., Chou, K., Fuchs, E., Havran, W. L. & Boismenu, R. Protection of the
intestinal mucosa by intraepithelial gd T cells. Proc. Natl Acad. Sci. USA 99,
14338–14343 (2002).
8. Fahrer, A. M. et al. Attributes of gd intraepithelial lymphocytes as suggested
by their transcriptional proﬁle. Proc. Natl Acad. Sci. USA 98, 10261–10266
(2001).
9. Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented ﬁlamentous
bacteria. Cell 139, 485–498 (2009).
10. Gaboriau-Routhiau, V. et al. The key role of segmented ﬁlamentous bacteria
in the coordinated maturation of gut helper T cell responses. Immunity 31,
677–689 (2009).
11. Round, J. L. & Mazmanian, S. K. The gut microbiota shapes intestinal immune
responses during health and disease. Nat. Rev. Immunol. 9, 313–323 (2009).
12. Ismail, A. S. et al. gd intraepithelial lymphocytes are essential mediators of
host-microbial homeostasis at the intestinal mucosal surface. Proc. Natl Acad.
Sci. USA 108, 8743–8748 (2011).
13. Roberts, S. J. et al. T-cell abþ and gdþ deﬁcient mice display abnormal but
distinct phenotypes toward a natural, widespread infection of the intestinal
epithelium. Proc. Natl Acad. Sci. USA 93, 11774–11779 (1996).
14. Smith, A. L. & Hayday, A. C. An ab T-cell-independent immunoprotective
response towards gut coccidia is supported by gd cells. Immunology 101,
325–332 (2000).
15. Ramsburg, E., Tigelaar, R., Craft, J. & Hayday, A. Age-dependent requirement
for gd T cells in the primary but not secondary protective immune response
against an intestinal parasite. J. Exp. Med. 198, 1403–1414 (2003).
16. Adkins, B., Leclerc, C. & Marshall-Clarke, S. Neonatal adaptive immunity
comes of age. Nat. Rev. Immunol. 4, 553–564 (2004).
17. Kuo, S., Guindy, El, A., Panwala, C. M., Hagan, P. M. & Camerini, V.
Differential appearance of T cell subsets in the large and small intestine of
neonatal mice. Pediatr. Res. 49, 543–551 (2001).
18. Williams, A. M. et al. Effects of microﬂora on the neonatal development of gut
mucosal T cells and myeloid cells in the mouse. Immunology 119, 470–478
(2006).
19. Sydora, B. C., Jamieson, B. D., Ahmed, R. & Kronenberg, M. Intestinal
intraepithelial lymphocytes respond to systemic lymphocytic choriomeningitis
virus infection. Cell Immunol. 167, 161–169 (1996).
20. London, S. D., Cebra, J. J. & Rubin, D. H. Intraepithelial lymphocytes contain
virus-speciﬁc, MHC-restricted cytotoxic cell precursors after gut mucosal
immunization with reovirus serotype 1/Lang. Reg. Immunol. 2, 98–102 (1989).
21. Dharakul, T., Rott, L. & Greenberg, H. B. Recovery from chronic rotavirus
infection in mice with severe combined immunodeﬁciency: virus clearance
mediated by adoptive transfer of immune CD8þ T lymphocytes. J. Virol. 64,
4375–4382 (1990).
22. Mu¨ller, S., Bu¨hler-Jungo, M. & Mueller, C. Intestinal intraepithelial
lymphocytes exert potent protective cytotoxic activity during an acute virus
infection. J. Immunol. 164, 1986–1994 (2000).
23. Bas, A. et al. Butyrophilin-like 1 encodes an enterocyte protein that selectively
regulates functional interactions with T lymphocytes. Proc. Natl Acad. Sci. USA
108, 4376–4381 (2011).
24. Der, S. D., Zhou, A., Williams, B. R. G. & Silverman, R. H. Identiﬁcation of
genes differentially regulated by interferon a, b, or g using oligonucleotide
arrays. Proc. Natl. Acad. Sci. USA 95, 15623–15628 (1998).
25. Zhou, Z. et al. Type III interferon (IFN) induces a type I IFN-like response
in a restricted subset of cells through signaling pathways involving both the
Jak-STAT pathway and the mitogen-activated protein kinases. J. Virol. 81,
7749–7758 (2007).
26. Liu, S.-Y., Sanchez, D. J., Aliyari, R., Lu, S. & Cheng, G. Systematic
identiﬁcation of type I and type II interferon-induced antiviral factors. Proc.
Natl Acad. Sci. USA 109, 4239–4244 (2012).
27. Ogasawara, K. et al. Requirement of the IFN-a/b-induced CXCR3 chemokine
signalling for CD8þ T cell activation. Genes Cells 7, 309–320 (2002).
28. Honda, K. et al. IRF-7 is the master regulator of type-I interferon-dependent
immune responses. Nature 434, 772–777 (2005).
29. Osterlund, P. I., Pietila¨, T. E., Veckman, V., Kotenko, S. V. & Julkunen, I. IFN
regulatory factor family members differentially regulate the expression of type
III IFN (IFN-l) genes. J. Immunol. 179, 3434–3442 (2007).
30. Levy, D. E., Marie´, I. J. & Durbin, J. E. Induction and function of type I and
III interferon in response to viral infection. Curr. Opin. Virol. 1, 476–486
(2011).
31. Clark, K. et al. Novel cross-talk within the IKK family controls innate
immunity. Biochem. J. 434, 93–104 (2011).
32. Tamura, A. et al. Distribution of two types of lymphocytes (intraepithelial and
lamina-propria-associated) in the murine small intestine. Cell Tissue Res. 313,
47–53 (2003).
33. Radojevic, N. et al. Characterization of enteric functional changes evoked by
in vivo anti-CD3 T cell activation. Am. J. Physiol. 276, R715–R723 (1999).
34. Garside, P., Felstein, M. V., Green, E. A. & Mowat, A. M. The role of interferon
a/b in the induction of intestinal pathology in mice. Immunology 74, 279–283
(1991).
35. Koerner, I., Kochs, G., Kalinke, U., Weiss, S. & Staeheli, P. Protective role of
beta interferon in host defense against inﬂuenza A virus. J. Virol. 81, 2025–2030
(2007).
36. Sommereyns, C., Paul, S., Staeheli, P. & Michiels, T. IFN-Lambda (IFN-l) is
expressed in a tissue-dependent fashion and primarily acts on epithelial cells
in vivo. PLoS Pathog. 4, e1000017 (2008).
37. Holzinger, D. et al. Induction of MxA gene expression by inﬂuenza A
virus requires type I or type III interferon signaling. J. Virol. 81, 7776–7785
(2007).
38. Flohr, F., Schneider-Schaulies, S., Haller, O. & Kochs, G. The central interactive
region of human MxA GTPase is involved in GTPase activation and interaction
with viral target structures. FEBS Lett. 463, 24–28 (1999).
39. Karst, S. M., Wobus, C. E., Lay, M., Davidson, J. & Virgin, H. W. STAT1-
dependent innate immunity to a Norwalk-like virus. Science 299, 1575–1578
(2003).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8090 ARTICLE
NATURE COMMUNICATIONS | 6:7090 | DOI: 10.1038/ncomms8090 |www.nature.com/naturecommunications 11
& 2015 Macmillan Publishers Limited. All rights reserved.
40. Wobus, C. E., Thackray, L. B. & Virgin, H. W. Murine norovirus: a model
system to study norovirus biology and pathogenesis. J. Virol. 80, 5104–5112
(2006).
41. Hsu, C. C., Riley, L. K., Wills, H. M. & Livingston, R. S. Persistent infection with
and serologic cross-reactivity of three novel murine noroviruses. Comp. Med
56, 247–251 (2006).
42. Wobus, C. E. et al. Replication of Norovirus in cell culture reveals a tropism for
dendritic cells and macrophages. PLoS Biol. 2, e432 (2004).
43. Nice, T. J. et al. Interferon-l cures persistent murine norovirus infection in the
absence of adaptive immunity. Science 347, 269–273 (2015).
44. Shortland, A. et al. Pathology caused by persistent murine norovirus infection.
J. Gen. Virol. 95, 413–422 (2014).
45. Ariotti, S. et al. T cell memory. Skin-resident memory CD8þ T cells trigger a
state of tissue-wide pathogen alert. Science 346, 101–105 (2014).
46. Schenkel, J. M. et al. T cell memory. Resident memory CD8 T cells
trigger protective innate and adaptive immune responses. Science 346, 98–101
(2014).
47. Gebhardt, T. et al. Memory T cells in nonlymphoid tissue that provide
enhanced local immunity during infection with herpes simplex virus. Nat.
Immunol. 10, 524–530 (2009).
48. Schenkel, J. M., Fraser, K. A., Vezys, V. & Masopust, D. Sensing and alarm
function of resident memory CD8þ T cells. Nat. Immunol. 14, 509–513
(2013).
49. Cauley, L. S. & LeFrancois, L. Guarding the perimeter: protection of the mucosa
by tissue-resident memory T cells. Mucosal Immunol. 6, 14–23 (2012).
50. Ariotti, S. et al. Tissue-resident memory CD8þ T cells continuously patrol skin
epithelia to quickly recognize local antigen. Proc. Natl Acad. Sci. USA 109,
19739–19744 (2012).
51. Kuss, S. K. et al. Intestinal microbiota promote enteric virus replication and
systemic pathogenesis. Science 334, 249–252 (2011).
52. Kane, M. et al. Successful transmission of a retrovirus depends on the
commensal microbiota. Science 334, 245–249 (2011).
53. Eagle, R. A. & Trowsdale, J. Promiscuity and the single receptor: NKG2D. Nat.
Rev. Immunol. 7, 737–744 (2007).
54. Hirose, K. et al. Interleukin-15 may be responsible for early activation of
intestinal intraepithelial lymphocytes after oral infection with Listeria
monocytogenes in rats. Infect. Immun. 66, 5677–5683 (1998).
55. Okazawa, A. et al. Human intestinal epithelial cell-derived interleukin (IL)-18,
along with IL-2, IL-7 and IL-15, is a potent synergistic factor for the
proliferation of intraepithelial lymphocytes. Clin. Exp. Immunol. 136, 269–276
(2004).
56. Saurer, L. et al. Virus-induced activation of self-speciﬁc TCRab CD8aa
intraepithelial lymphocytes does not abolish their self-tolerance in the intestine.
J. Immunol. 172, 4176–4183 (2004).
57. Komano, H. et al. Homeostatic regulation of intestinal epithelia by
intraepithelial gd T cells. Proc. Natl Acad. Sci. USA 92, 6147–6151 (1995).
58. Onoguchi, K. et al. Viral infections activate types I and III interferon genes
through a common mechanism. J. Biol. Chem. 282, 7576–7581 (2007).
59. van Boxel-Dezaire, A. H. H. et al. Major differences in the responses of primary
human leukocyte subsets to IFN-b. J. Immunol. 185, 5888–5899 (2010).
60. Taniguchi, T. & Takaoka, A. A weak signal for strong responses: interferon-a/b
revisited. Nat. Rev. Mol. Cell. Biol. 2, 378 (2001).
61. Pott, J. et al. IFN-l determines the intestinal epithelial antiviral host defense.
Proc. Natl Acad. Sci. USA 108, 7944–7949 (2011).
62. Hotamisligil, G. S. Endoplasmic reticulum stress and the inﬂammatory basis of
metabolic disease. Cell 140, 900–917 (2010).
63. MacMicking, J. D. IFN-inducible GTPases and immunity to intracellular
pathogens. Trends Immunol. 25, 601–609 (2004).
64. Schnoor, M., Betanzos, A., Weber, D. A. & Parkos, C. A. Guanylate-binding
protein-1 is expressed at tight junctions of intestinal epithelial cells in response
to interferon-gamma and regulates barrier function through effects on
apoptosis. Mucosal Immunol. 2, 33–42 (2009).
65. Lopman, B. et al. Increase in viral gastroenteritis outbreaks in Europe and
epidemic spread of new norovirus variant. Lancet 363, 682–688 (2004).
66. Monroe, S. S. Control and prevention of viral gastroenteritis. Emerging Infect.
Dis 17, 1347–1348 (2011).
67. Vidal, K., Grosjean, I., Revillard, J. P., Gespach, C. & Kaiserlian, D.
Immortalization of mouse intestinal epithelial cells by the SV40-large T gene.
Phenotypic and immune characterization of the MODE-K cell line. J. Immunol.
Methods 166, 63–73 (1993).
68. Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs
with plasmacytoid morphology. Nat. Immunol. 2, 1144–1150 (2001).
69. Blasi, E., Barluzzi, R., Bocchini, V., Mazzolla, R. & Bistoni, F. Immortalization
of murine microglial cells by a v-raf/v-myc carrying retrovirus. J.
Neuroimmunol. 27, 229–237 (1990).
70. Reed, L. J. & Muench, H. A simple and reliable method of estimating ﬁfty per
cent end points. Am. J. Hyg. 27, 493–497 (1938).
Acknowledgements
Support was provided by the Wellcome Trust (A.C.H., J.L.H., G.R) and Cancer Research
UK (A.C.H.), Department of Health via the National Institute for Health Research
(NIHR) comprehensive Biomedical Research Centre award to Guy’s & St Thomas’ NHS
Foundation Trust (L.A.-D.; A.C.H.); Marie Curie and EMBO fellowships (M.S.). We
thank Professor D. Cantrell for generous support of M.S.; Dr D. Kaiserlien (Lyon) for the
gift of MODE-K cells; Dr B. Spencer-Dene for histological stainings; Dr P. East for
contributing to microarray data analysis, and our many colleagues for useful discussions
and criticisms, particularly Dr V. Hornung. We acknowledge the staffs of the ﬂow
cytometry and animal care facilities of the Francis Crick Institute, Lincoln’s Inn Fields
Laboratories, London, UK, King’s College London, and the Universities of Freiburg,
Cambridge, and Dundee.
Author contributions
M.S., L.A.-D., J.C., T.M. and D.G. designed and undertook experiments and analysed
data; P.C. analysed microarray data; G.R. conducted experiments and analysed data;
C.R.eS., P.S., B.A.B. and J.L.H. contributed ideas and key reagents and helped design and
interpret experiments; M.S. and A.C.H. designed the study and individual experiments,
analysed the data and wrote the manuscript.
Additional information
Accession codes. The microarray data have been deposited in the NCBI Gene Expression
Omnibus (GEO) database with accession code GSE63364.
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Swamy, M. et al. Intestinal intraepithelial lymphocyte activation
promotes innate antiviral resistance. Nat. Commun. 6:7090 doi: 10.1038/ncomms8090
(2015).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8090
12 NATURE COMMUNICATIONS | 6:7090 |DOI: 10.1038/ncomms8090 |www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
